Abstract
Health care personnel experience rates of substance-use disorders (abuse and dependence) that are comparable to the general public. Unlike the general population, however, physicians are more likely than nonphysicians to misuse prescription drugs and to do so for reasons of self-treatment. There are a number of nonspecific signs and symptoms that might suggest a problem, and being familiar with these is important for all physicians. If there is a problem, intervening as early as possible is important, both for the health of the physician and for his or her patients. The best approach for intervening with physicians is one that is highly structured. Residential programs of 2–3 months in duration are often recommended, but there is scant evidence that these extended stays produce better outcomes than shorter stays. If a physician has undergone extended inpatient treatment, aftercare plans generally include monitoring by a state physician health program. These programs can provide advocacy for physicians who have maintained abstinence and complied with all aspects of their monitoring agreements. Success rates for physicians who undergo substance-use disorders treatment and/or monitoring are generally very high, probably because the costs of failure and the rewards of success are both very high for doctors. Many physicians who have been caught in the grips of a substance-use disorder recover fully and return to the successful practice of medicine, and might even be better physicians given their newfound focus on their own health and well-being.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agius R, Kintz P, European Workplace Drug Testing Society. Guidelines for European workplace drug and alcohol testing in hair. Drug Test Anal. 2010;2(8):367–76.
Baldisseri MR. Impaired healthcare professional. Crit Care Med. 2007;35(2 Suppl):S106–16.
Boyd JW. Deciding whether to refer a colleague to a physician health program. AMA J Ethics. 2015;17(10):888–93.
Boyd JW. State physician health programs require national standards and external oversight. J Psychiatry. 2016;19:1.
Boyd JW, Knight JR. Ethical and managerial considerations regarding state physician health programs. J Addict Med. 2012;6(4):243–6.
Bright RP, Krahn L. Impaired physicians: how to recognize, when to report, and where to refer. Curr Psychiatr Ther. 2010;9:11–20.
Brooke D, Edwards G, Taylor C. Addiction as an occupational hazard: 144 doctors with drug and alcohol problems. Br J Addict. 1991;86(8):1011–6.
Centrella M. Physician addiction and impairment-current thinking: a review. J Addict Dis. 1994;13(1):91–105.
DesRoches CM, Rao SR, Fromson JA, Birnbaum RJ, Iezzoni L, Vogeli C, Campbell EG. Physicians’ perceptions, preparedness for reporting, and experiences related to impaired and incompetent colleagues. JAMA. 2010;304(2):187–93.
Domino KB, Hornbein TF, Polissar NL, Renner G, Johnson J, Alberti S, Hankes L. Risk factors for relapse in health care professionals with substance use disorders. JAMA. 2005;293(12):1453–60.
Dyrbye LN, Thomas MR, Shanafelt TD. Medical student distress: causes, consequences, and proposed solutions. Mayo Clin Proc. 2005;80(12):1613–22.
DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: physicians’ Health Programs. J Subst Abus Treat. 2009;36(2):159–71.
Frank E. We physicians preach what we practice, and that matters. MedGenMed. 2007;9(4):59.
Gold KJ, Goldman EB, Kamil LH, Walton S, Burdette TG, Moseley KL. No appointment necessary? Ethical challenges in treating friends and family. NEJM. 2014;371:1254–8.
Hughes PH, Brandenburg N, Baldwin DC, Storr CL, Williams KM, Anthony JC, Sheehan DV. Prevalence of substance use among US physicians. JAMA. 1992;267(17):2333–9.
Hughes PH, Storr CL, Brandenburg NA, Baldwin Jr DC, Anthony JC, Sheehan DV. Physician substance use by medical specialty. J Addict Dis. 1999;18(2):23–37.
Kenna GA, Lewis DC. Risk factors for alcohol and other drug use by healthcare professionals. Subst Abuse Treat Prev Policy. 2008;3(1):1.
Knight JR, Sanchez LT, Sherritt L, Bresnahan L, Fromson JA. (2007). Outcomes of a monitoring program for physicians with mental and behavioral health problems. J Psychiatr Pract. 2007;13(1):25–32.
Mahmood JI, Grotmol KS, Tesli M, Vaglum P, Tyssen R. Risk factors measured during medical school for later hazardous drinking: a 10-year, longitudinal, nationwide study (NORDOC)dagger. Alcohol Alcohol. 2016;51(1):71–6.
Martinez S, Tal I, Norcross W, Newton IG, Downs N, Seay K, Lee D. Alcohol use in an academic medical school environment: a UC San Diego Healer Education Assessment and Referral (HEAR) Report. Ann Clin Psychiatry. 2016;28(2):85.
McAuliffe WE, Rohman M, Breer P, Wyshak G, Santangelo S, Magnuson E. Alcohol use and abuse in random samples of physicians and medical students. Am J Public Health. 1991;81(2):177–82.
McAuliffe WE, Rohman M, Santangelo S, et al. Psychoactive drug use among practicing physicians and medical students. N Engl J Med. 1986;315(13):805–10.
Oreskovich MR, Shanafelt T, Dyrbye LN, Tan L, Sotile W, Satele D, West CP, Sloan J, Boone S. The prevalence of substance use disorders in American physicians. Am J Addict. 2015;24(1):30–8. doi: 10.1111/ajad.12173
Rose JS, Campbell MD, Yellowlees P, Skipper GE, DuPont RL. Family medicine physicians with substance use disorder: a 5-year outcome study. J Addict Med. 2017. doi:10.1097/ADM.0000000000000278.
Rosta J. Hazardous alcohol use among hospital doctors in Germany. Alcohol Alcohol. 2008;43(2):198–203.
Rosta J, Aasland OG. Changes in alcohol drinking patterns and their consequences among Norwegian doctors from 2000 to 2010: a longitudinal study based on national samples. Alcohol Alcohol. 2013;48(1):99–106.
Rosta J, Aasland OG. Female surgeons’ alcohol use: a study of a national sample of Norwegian doctors. Alcohol Alcohol. 2005;40(5):436–40.
Sen S, Kranzler HR, Krystal JH, Speller H, Chan G, Gelernter J, Guille C. A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry. 2010;67(6):557–65.
Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs. Anesth Analg. 2009;109(3):891–6.
Sorensen JK, Pedersen AF, Bruun NH, Christensen B, Vedsted P. Alcohol and drug use among Danish physicians. A nationwide cross-sectional study in 2014. Dan Med J. 2015;62(9):A5132.
Swotinsky RB. The medical review officers manual: MROCC’s guide to drug testing. Beverly Farms: OEM Press; 2015.
Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26(2):200–5.
Voigt K, Twork S, Mittag D, Gobel A, Voigt R, Klewer J, et al. Consumption of alcohol, cigarettes and illegal substances among physicians and medical students in Brandenburg and Saxony (Germany). BMC Health Serv Res. 2009;9(1):1.
Wunsch MJ, Knisely JS, Cropsey KL, Campbell ED, Schnoll SH. Women physicians and addiction. J Addict Dis. 2007;26(2):35–43.
Yellowlees PM, Campbell MD, Rose JS, Burke Parish M, Ferrer D, Scher LM, Skipper GE, DuPont RL. Psychiatrists with substance use disorders: positive treatment outcomes from physician health programs. Psychiatr Serv. 2014;65(12):1492–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Wesley Boyd, J. (2017). Substance Use and Addictive Behaviors Among Physicians. In: Brower, K., Riba, M. (eds) Physician Mental Health and Well-Being. Integrating Psychiatry and Primary Care. Springer, Cham. https://doi.org/10.1007/978-3-319-55583-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-55583-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55582-9
Online ISBN: 978-3-319-55583-6
eBook Packages: MedicineMedicine (R0)